Paper II
2018 July (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Treatment of multi drug resistance tuberculosis

Q33 marksShort Notes

Answer

Multidrug-resistant tuberculosis (MDR-TB) is resistant to at least isoniazid and rifampicin.

Treatment principles

  • Requires an individualized regimen with at least 4–5 effective second-line drugs, guided by drug-susceptibility testing, given for a prolonged duration (18–24 months in older regimens; newer shorter regimens available)

Drugs used

  • Fluoroquinolones: Levofloxacin, Moxifloxacin
  • Second-line injectables: Kanamycin, Amikacin, Capreomycin (largely phased out in newer regimens)
  • Newer oral agents: Bedaquiline, Linezolid, Clofazimine, Delamanid
  • Other second-line agents: Cycloserine, Ethionamide, Para-aminosalicylic acid (PAS)

Key points

  • Directly Observed Treatment (DOT) is essential to ensure adherence
  • Newer all-oral, shorter regimens (e.g., BPaL — Bedaquiline, Pretomanid, Linezolid) have improved outcomes and reduced treatment duration

Other Years Asked


Revise MBBS
Preview